The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

Knowledgeable Insights: Lunsumio VELO’s Quick Follicular Lymphoma Remedy

Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its influence on sufferers with relapsed or...

Bettering Entry to Genomics-Primarily based Trials By Affected person Schooling

Bettering equitable entry to genomics-based medical trials stays a essential precedence in most cancers care, in keeping with Dr. Nadine A. Jackson,...

How CAN-3110 Works to Deal with Glioblastoma

After being given months to dwell following a 2021 analysis of glioblastoma, Kyle Donahue enrolled in a groundbreaking scientific trial at Brigham...

The Three Remedy Pillars of Pancreatic Most cancers

Dr. Benjamin Jon Golas of Hackensack Meridian Well being mentioned the principle methods for treating pancreas most cancers, specializing in surgical procedure,...

Tecvayli Related With Lowered Danger of Myeloma Development or Demise

Amongst sufferers with relapsed or refractory a number of myeloma, Tecvayli (teclistamab-cqyv) monotherapy was related to a 71% discount within the threat...

Hot Topics